Governance

Jean-Marc Bellemin brings over 30 years of international experience in finance, operations, and corporate strategy in the pharmaceutical and biotech sectors.

He has held leadership roles at companies including Actelion Pharmaceuticals, Gritstone Oncology, and Iovance Biotherapeutics, where he served as Chief Financial Officer and played a central role in financing strategy, corporate growth, and global commercialization efforts.

Jean-Marc joined Chiesi Group in July 2025 as Group Chief Financial Officer and member of the Group Executive Leadership Team, contributing to the company’s financial strategy, operations management, and long-term business planning. Since 15 May 2026, he has also served as Interim CEO.

Jean-Marc holds a Bachelor of Science in Economics and Management from Paris Dauphine University, a Master’s in Finance and Accounting from Paris Sorbonne University, and an MBA from ESSEC Business School.

He also completed the General Management Program at Harvard Business School.